Industry reports
Editor highlights

Biological Therapy Industry in South Korea: Market Research Reports, Statistics and Analysis

You might be interested in: cell therapy, stem cell, cell culture, more »

» View Public Reports

11 reports

Biological Therapy Sector in South Korea

  • Industry report
  • April 2012
  • 11 pages
  • by Corporation

... Is a human keratinocyte line that rele- ases abnormal level of chemokines, including tarc, mdc, rantes, vascular endothelial growth factor, and eotaxin when stimulated with tnf- And ifn- . When released from ...

The South Korean Cell Therapy Market : Innovation and Technology Trends

  • Industry report
  • May 2012
  • 11 pages
  • by Corporation

... To reduce time and cost associated with developing and introducing biopharmaceutical drugs for human and animal vaccines, cell therapy, and other cell culture and fermentation applications. Copyright 2012 ...

Company Report: Gene Therapy in South Korea for Year 2012

  • Company report
  • March 2012
  • 6 pages

... Engineering research products Standing as korea S leading biotech player, bioneer specializes in developing molecular diagnostic products, gene therapy drugs, and genetic engineering research products ...

Company Report: Gene Therapy in South Korea for Year 2012

  • Company report
  • March 2012
  • 6 pages

... Production methods are limited by the fact that they involve a large series of complex processes, including dna extraction, host cell transformation, cell culturing, protein isolation, and protein ...

Samsung Group - Company Report for Year 2011

  • Company report
  • September 2011
  • 43 pages

... Biotech. 7 Healthcare market entry by conglomerates company business business developments samsung samsung electronics stem-cells - begin research on new medical technology that converges ...

Company Report: Stem Cell in South Korea for Year 2011

  • Company report
  • September 2011
  • 16 pages

... Blood (stem cells) ability to migrate to area of injury/defect source to treat adult diseases cerebral palsy pediatric diabetes 1.Cord blood is blood that remains in the placenta and in the attached ...

Company Report: Gene Therapy in South Korea, The United States and China for Year 2011

  • Company report
  • March 2011
  • 48 pages

... Believe gene therapy will emerge as a complementary medication to existing therapies. Treatment using multiple genes will likely become possible; moreover, there should be no need for gene therapy ...

Company Report: Biological Therapy in South Korea and The United States for Year 2011

  • Company report
  • March 2011
  • 5 pages

... Are under development in the u.S., 3) The r&d progress for biobetters and biosimilars, and 4) the sales performance of cartistem (an umbilical cord blood stem cell therapy). February 13, 2012 company ...

Search in Biological Therapy Industry

» Purchase Premium Reports (From $ 250 - $ 250)

9 reports
RNL BIO Co., Ltd. (003190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RNL BIO Co., Ltd. (003190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary RNL BIO Co., Ltd. (RNL BIO) is a biotechnology company, based in Republic of Korea. The company develops, manufactures and markets stem cell therapy products. It offers products and services in ...

Regenetech, Inc. - Pharmaceuticals & Healthcare - Deals ...

January 2014 $ 250

Pharmicell Co., Ltd. (005690) - Pharmaceuticals & Healt ...

January 2014 $ 250

Cha Bio & Diostech Co., Ltd. (085660) - Pharmaceuticals ...

January 2014 $ 250

Rnl Bio Co., Ltd. (cbteq.pk) - Pharmaceuticals & Health ...

July 2013 $ 250

Ips Cell Generation Patent Landscape - 2013/03

May 2013 $ 6 860

Ips Cell Differentiation Patent Landscape - 2013/03

May 2013 $ 4 060

Competitor Analysis: G-csf And Gm-csf

April 2013 $ 528

Stem Cell Therapy Market In Asia-pacific To 2018 - Comm ...

December 2012 $ 3 500

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.